Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China · Delayed Price · Currency is CNY 28.70
-0.22 (-0.76%)
At close: Sep 4, 2026
SHA:688273 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 73.17 | 102.63 | 101.58 | 89.82 | 121.68 | 118.38 |
Depreciation & Amortization | 29 | 28.1 | 26.68 | 17.84 | 14.47 | 11.42 |
Other Amortization | 5.23 | 3.88 | 2.32 | 2.29 | 3.14 | 1.68 |
Loss (Gain) From Sale of Assets | -0.36 | -0.19 | 0.12 | -0.23 | 0 | -0.31 |
Asset Writedown & Restructuring Costs | -0.64 | 0.98 | 9.94 | - | - | - |
Loss (Gain) From Sale of Investments | -8.61 | -9 | -5.07 | -14.54 | -7.97 | -4.77 |
Provision & Write-off of Bad Debts | 1.25 | 1.25 | 0.81 | 0.45 | 2.84 | 0.55 |
Other Operating Activities | 0.68 | 1.5 | 8.93 | 3.71 | 8.33 | 1.75 |
Change in Accounts Receivable | -4.32 | -12.54 | -9.48 | 16.38 | -16.48 | 2.61 |
Change in Inventory | -14.33 | -1.3 | -16.13 | 16.09 | -31.03 | -18.04 |
Change in Accounts Payable | -0.99 | 0.95 | -1.54 | 3.37 | 23.09 | 32.14 |
Change in Other Net Operating Assets | -4.04 | -0.62 | -0.01 | 4.74 | 5.39 | 4.95 |
Operating Cash Flow | 66.53 | 105.43 | 122.51 | 136.91 | 126.67 | 148.6 |
Operating Cash Flow Growth | -37.00% | -13.94% | -10.52% | 8.08% | -14.75% | 13.35% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -68.6 | -118.15 | -129.71 | -75.15 | -54.26 | -14.58 |
Sale of Property, Plant & Equipment | -0.09 | 0.35 | 0.75 | 0.57 | 0.03 | 0.36 |
Cash Acquisitions | - | - | -17.29 | -10.5 | - | - |
Divestitures | 30.25 | - | - | - | - | - |
Investment in Securities | 119.41 | 448.8 | -347.4 | -166.58 | -40 | - |
Other Investing Activities | 9.46 | 12.37 | -14.42 | 14.23 | 7.93 | 5.5 |
Investing Cash Flow | 90.42 | 343.37 | -508.07 | -237.43 | -86.31 | -8.73 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 19.02 | 7 | - | - | - |
Total Debt Issued | 30.95 | 19.02 | 7 | - | - | - |
Short-Term Debt Repaid | - | -13 | -6.73 | - | - | -7.34 |
Long-Term Debt Repaid | - | -4.39 | -10.89 | -4.44 | -6.96 | -3.06 |
Lease Payments | -4.39 | -4.39 | -10.89 | -4.44 | -6.96 | -3.06 |
Total Debt Repaid | -18.51 | -17.39 | -17.62 | -4.44 | -6.96 | -10.39 |
Net Debt Issued (Repaid) | 12.45 | 1.63 | -10.62 | -4.44 | -6.96 | -10.39 |
Issuance of Common Stock | - | - | - | 13.12 | 938.53 | - |
Repurchase of Common Stock | -1.33 | -1.33 | -46.4 | -18.47 | - | - |
Common Dividends Paid | -81.35 | -69.14 | -98.9 | -82.22 | -50 | -0.03 |
Other Financing Activities | 4.16 | -6.96 | -8.6 | 8.32 | -18.22 | -7.14 |
Financing Cash Flow | -66.07 | -75.8 | -164.52 | -83.69 | 863.34 | -17.57 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.2 | -0.05 | 0.02 | 0.01 | 0.01 | - |
Net Cash Flow | 90.68 | 372.94 | -550.07 | -184.21 | 903.71 | 122.3 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.08 | -12.73 | -7.2 | 61.76 | 72.41 | 134.01 |
Free Cash Flow Growth | - | - | - | -14.71% | -45.97% | 27.41% |
Free Cash Flow Margin | -0.54% | -2.95% | -1.70% | 18.12% | 19.21% | 39.23% |
Free Cash Flow Per Share | -0.02 | -0.13 | -0.07 | 0.62 | 0.87 | 1.79 |
Levered Free Cash Flow | 57.33 | 7.6 | -41.98 | 24.83 | 21.54 | 76.5 |
Unlevered Free Cash Flow | 58.19 | 8.47 | -41.31 | 25.06 | 21.72 | 76.59 |
Free Cash Flow After Leases | -6.47 | -17.12 | -18.09 | 57.32 | 65.45 | 130.96 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 33.64 | 39.49 | 32.2 | 41.1 | 22.65 | 37.03 |
Change in Working Capital | -33.19 | -23.72 | -22.82 | 37.58 | -15.82 | 19.89 |